Related by context. All words. (Click for frequent words.) 76 carryforwards 72 loss NOL carryforward 72 loss carryforward 71 NOL carryforward 71 operating loss carryforwards 69 loss carryforwards 69 NOLs 68 share repurchase authorizations 65 loss carryovers 64 adopting SFAS #R 64 realizability 64 Visa indemnification 64 accounts receivable balances 64 carryforward 64 NOL utilization 63 Unlevered Cash Flow 63 normalized FFO 63 operatingincome 63 adopted SFAS #R 63 loss carrybacks 63 repurchase authorizations 63 asset monetizations 62 c Calculated 62 c Represents 62 unevaluated properties 62 FDIC indemnification 62 DAC unlocking 62 debt extinguishments 62 FAFLIC 62 credit carryforwards 62 MFB Corp 62 accumulated undistributed 62 estimated undiscounted 61 stock basedcompensation 61 millioncompared 61 normalized FFO guidance 61 FDIC indemnification asset 61 OTTI charges 61 d Represents 61 NETg acquisition 61 LIFO adjustment 61 financialstatements 61 DAC unlock 61 netincome 61 VIOXX Lawsuits 61 uncollectible accounts receivable 61 Lifecomm Joint Venture 61 LIFO accounting 60 receivable balances 60 Adjusted EBITDA excludes 60 asset valuation allowance 60 undistributed earnings 60 addback 60 unitholder distributions 60 exchangeable debentures 60 per dilutedshare 60 Core FFO 60 #.# perdiluted 60 MFFO 60 OPEB expense 60 valuation allowances 60 earnings pershare 60 No. #R 59 OTTI write downs 59 #.#per diluted 59 adjusted EBITDAR 59 Consolidated EBITDAR 59 Pro forma Adjusted EBITDA 59 EBDDT 59 noncash goodwill 59 condensed consolidated balance sheets 59 hedge ineffectiveness 59 valuation allowance 59 nondeductible portion 59 securitized receivables 59 Equity Investees 59 earnout payment 59 amortizable intangible assets 59 Repurchase Program 58 LAE reserves 58 undrawn revolver 58 unfavorable variances 58 noninterest expense decreased 58 Excess Cash Flow 58 securitized accounts receivable 58 continuingoperations 58 Possible Loan Losses 58 Adjusted FIFO EBITDA 58 CGAAP 58 nondividend distribution 58 nondeductible expenses 58 carrybacks 58 temporary impairments OTTI 58 condensed consolidated balance sheet 58 revolver borrowings 58 SFAS No.# 58 Asset Retirement Obligation 58 Predecessor Period 58 IBNR reserves 58 accretable yield 58 forwards NOLs 58 LILO transactions 58 b Excludes 58 Partnered Brands segment 58 Convertible Debt 58 intangible assets impairment 58 nonroutine income 58 TASE EVGN.TA 58 unconsolidated investee 58 USOGP 58 Consolidated Adjusted EBITDA 58 Non GAAP Adjusted EBITDA 58 unaudited consolidated balance sheets 58 Pro Forma EBITDA 58 Debt Settlement Agreements 58 intercompany indebtedness 58 f Represents 58 FFO FAD 58 ofapproximately 58 Adjusted EBTIDA 58 reasonably estimable 58 nonoperating expense 58 covenant calculations 57 UILIC 57 NOL Protective Measures 57 #.#/diluted share 57 Interest Expense Interest expense 57 carryback 57 MEP Joint Venture 57 Contingent Consideration 57 FSAH 57 Filtran Microcircuits Inc. 57 Note Receivable 57 Airesurf 57 Adjusted FFO 57 defeased loans 57 Barrett NDEx 57 depletion calculation 57 depreciable assets 57 pro forma adjusted EBITDA 57 EBIAT 57 b Represents 57 foreign currency remeasurement 57 fiscal# 57 escrowed funds 57 PGP Acquisition 57 Petition Date 57 retrospectively adjusted 57 unrealized derivative gains 57 Pro forma adjusted EBITDA 57 FFO payout ratio 57 Unizan merger 57 marketable securities 57 Panamax Bulk Carrier 57 Recurring FFO 57 REIT taxable 57 intersegment transactions 57 Excluding nonrecurring items 57 nonaccrual loan 57 DJOFL 57 infrequently occurring 57 nonrecurring expenses 57 AOCL 57 Timeshare segment 57 Senior Exchangeable Notes 57 OTTI charge 57 undepreciated 57 prorata 57 Adjusted OIBA 57 noncash impairments 57 c Reflects 56 SFAS#R 56 - Adjusted [030] 56 Individual Annuities segment 56 receivables securitization facility 56 d Reflects 56 contractual minimums 56 FAS# R 56 Hardwoods LP 56 elective deferrals 56 unaccreted discount 56 Petrojarl Varg FPSO 56 Crisa acquisition 56 unamortized portion 56 noncash pretax charge 56 COLI policies 56 Projected FFO 56 subordinated convertible notes 56 Normalized FFO 56 Merged Entity 56 Rosebel royalty 56 EnPro consolidated 56 profitsharing 56 Medicare Advantage MLR 56 uncollectable receivables 56 unamortized deferred 56 prorations 56 Unitholder distributions 56 Promotions.com subsidiary 56 unexercised warrants 56 amortizable 56 QSBS 56 Subordinated Note 56 undepreciated assets 56 depreciation amortization depletion 56 FSP #-# 56 actuarially determined 56 principal paydowns 56 Subordinated Convertible Notes 56 cash equivalents marketable securities 56 nonGAAP 56 RRSP contribution room 56 c Relates 56 RAPTIVA R 56 f Reflects 56 Pro forma EPS 56 QUALCOMM pro forma 56 noncurrent liabilities 56 prioryear 56 Adjusted EBITDAX 56 Real Estate Owned OREO 56 ASC #-#-# 56 Katonah Debt Advisors 56 ceding commissions 56 accruals 56 pershare 56 NYSE MIM MID 56 unbooked resource potential 56 b Reflects 56 currency remeasurement 56 Kereco 56 voluntary prepayment 56 intangible impairment 56 non recourse RISPERDAL 56 PDP MLR 56 adopting SFAS 56 Comparable FFO 56 Subordinate MBS portfolio 56 Stockholder Rights Plan 56 Revolving Credit Agreement 56 capitalizable 56 depreciation accretion 56 Symphony GenIsis 56 accretion expense 56 refranchising transactions 55 FSP FAS #-# 55 amortization expense 55 Transferred Assets 55 reinsurance commutations 55 exclude noncash 55 doubtful accounts receivable 55 nonforfeitable 55 excluding AOCI 55 GMDB 55 Vishay stockholders 55 Endo Pharma LLC 55 operating income1 55 undistributed taxable income 55 inventories revalued 55 Consolidated OIBDA 55 endedDecember 55 retroactively restated 55 unvested options 55 Shelf Registration 55 unbilled revenue 55 Operational EBITDA 55 applied prospectively 55 Cortelco 55 junior subordinated debentures 55 suchstatements 55 Teekay Petrojarl ASA 55 earnout payments 55 forward lookinginformation 55 Nonoperating 55 TEB adjustment 55 Hardwoods USLP 55 Novogyne 55 ninemonths ended 55 X Ceptor 55 Medicare Advantage PFFS 55 indemnification obligations 55 Lasertel subsidiary 55 FSP EITF #-#-# [002] 55 reorganized Calpine 55 excludes depreciation amortization 55 subordinated promissory notes 55 commonstock 55 borrowable resources 55 taxable equivalent FTE 55 undiscounted cash 55 Vyvx Advertising Distribution 55 INOVA Geophysical 55 ABL Facility 55 subordinated CMBS 55 buyback authorizations 55 rentable square footage 55 undrawn revolver capacity 55 LIFO adjustments 55 MDP Transaction 55 ASC #-# 55 Including discontinued operations 55 Cash Flow Swap 55 Exchangeable Debentures 55 share repurchase authorization 55 AFFO payout ratio 55 Earnout 55 No. #R Share 55 incentive accruals 55 BioMarin Genzyme LLC 55 SIFT Tax 55 ended September# 55 Acquired Assets 55 Innovis Entities 55 EPADS estimates 55 Term Securitization 55 SFAS# R 55 Astaris joint venture 55 accounts receivable securitization 55 Contingent consideration 55 materially misstated 55 EITF #-# [001] 55 toreflect 55 contingently convertible debt 55 - Adjusted [012] 55 ATCF 55 accrual reversal 55 DTHC 55 DEPS guidance 55 realizable value 55 theseforward looking 55 Stock Repurchase Plan 55 SFSB transaction 54 Inc HGIC 54 includible 54 Senior Secured Term 54 COGP 54 § #-#-# b [001] 54 pro forma EBITDA 54 LIFO inventory 54 EBITDAO 54 forward lookingstatement 54 Oxy ER 54 lump sum distributions 54 modified coinsurance 54 Funded Debt 54 rent escalations 54 mandatorily redeemable 54 standardized distributable cash 54 subordinated indebtedness 54 items affecting comparability 54 distort comparability 54 OPANA franchise 54 NAREIT definition 54 early extinguishments 54 underwriting discounts commissions 54 current NAREIT definition 54 USD#.#m USD#.# per [002] 54 GSCT program 54 calculates FFO 54 income teb 54 warranty accruals 54 Domilens 54 contingently issuable shares 54 Arana Therapeutics Limited 54 Jiantou Xinyuan 54 forward.looking statements 54 Primedex 54 ended December# 54 Ps.6 54 Remainco 54 Contingent Value Rights 54 Accelerated Share Repurchase 54 Excluding goodwill impairment 54 normalized EBIT 54 Acquired Intangible Assets 54 noncash goodwill impairment 54 postretirement benefit plans 54 excluding BIBP 54 aC corporation 54 unsecured subordinated debentures 54 postretirement benefit 54 unrealized derivative 54 MtM impacts 54 Teekay Parent 54 non gaap 54 FASB Interpretation No. 54 FAS #R Share 54 Pro forma EBITDA 54 THALOMID 54 Surface Specialties acquisition 54 actuarial liabilities 54 undistributed net 54 aftertax charge 54 eCOST 54 underwriters overallotment option 54 materiality threshold 54 DiaMed acquisition 54 convertible promissory notes 54 OP Unit 54 nonoperating expenses 54 #compared 54 USPoly 54 Copano commodity 54 Income Applicable 54 Ps.3 54 Noninterest expense decreased 54 ceded reinsurance 54 results ofoperations 54 Managed Basis 54 ChannelRe 54 substantively enacted 54 EXLP 54 Successor Period 54 Pro forma adjustments 54 adjusted EBITDAS 54 PNOI 54 LIFO inventory valuation 54 4Q FY# 54 Standardized distributable cash 54 Loan Payable 54 HLTH Corporation 54 Neurogen stockholders 54 THE JEAN COUTU 54 depreciation depletion amortization 54 retroactive reinstatement 54 receivables securitization 54 CICA Accounting Guideline 54 Mowood 54 CAD#m [002] 54 Adjusted Pro Forma 54 Thalomid ® 54 Theseforward looking 54 Convertible Promissory Notes 54 Subordinate MBS 54 promissory note receivable 54 CFFO 54 convertible subordinated notes 54 prepetition liabilities 54 ascompared 54 ALICO Holdings 54 Reclassifications 54 senior subordinated convertible 54 Adjusted EBIDTA 54 FIN #R 54 Xantic acquisition 54 MZT Holdings 54 USD#.#m USD#.# [002] 54 minimally dilutive 54 SEK -#.# -#.# [003] 54 IBNR reserve 54 intercompany receivables 54 months endedSeptember 54 postretirement obligations 54 cash flows 54 contingently convertible securities 54 harbor provisions 54 Adjusted Earnings 54 promissory notes payable 54 aftertax gain 54 invoiced shipments 54 nine monthsended 54 SBIC debentures 54 Gosman Estate 54 Cobalt Gordian 53 unsecured indebtedness 53 Oxandrin 53 unfunded accrued 53 defease 53 BPLP 53 covenant ratios 53 MSR impairment 53 unrealized derivative losses 53 adjusted distributable cash 53 Normalized EPS 53 Stock Buyback Program 53 AutoZone repurchased 53 REIT Exemption 53 Hexion Proposal 53 Tax Attributes 53 opportunistically repurchase 53 TBtu 53 DSUs 53 Non GAAP adjusted EBITDA 53 Interest expense decreased 53 Canexus LP 53 SFSB Inc. 53 Radian Asset 53 noncash amortization 53 QCRH 53 Pro forma diluted 53 intersegment revenues 53 unrealized derivative gain 53 accretable 53 SS NOI 53 rebased amounts 53 Contingent Convertible Senior 53 LibertyBank Acquisition 53 calculating FFO 53 nonvested 53 Invested Capital ROIC 53 Exterran Holdings indirectly 53 unamortized issuance costs 53 FFO allocable 53 unamortized discount 53 Specified Investment 53 Final Liquidating Distribution 53 Compensation Expense 53 Boardwalk Pipeline 53 Noninterest Expense Noninterest expense 53 balance sheet securitizations 53 Fitch BBB medians 53 redeemable preferred stock 53 unamortized financing 53 taxable income 53 -Amos Harel Haaretz Correspondent 53 Financing Transactions 53 Unfunded commitments 53 Reconciling Items 53 Comparable Basis 53 involve risksand uncertainties 53 Payment FAS #R 53 diluted EPS 53 CAD1 53 SBIC leverage 53 IAROC 53 BUSINESS OUTLOOK 53 Share repurchases 53 FSAH acquisition 53 Gramercy Realty 53 financialperformance 53 Chemicals Segment 53 franking credits attached 53 expenses totaled Ps 53 nonrecurring 53 - - Net [047] 53 accrual 53 Annual Incentive Plan 53 Gross Addition CPGA 53 Business.com Acquisition 53 Standardized Measure 53 NMHG Retail 53 excludes noncash 53 discount accretion 53 depreciable real estate 53 recourse indebtedness 53 Adjusted EBITDA1 53 Zunicom Inc. 53 ATI Ladish 53 NeedleTech 53 Rev. Rul 53 intangible impairments 53 fiscalyear 53 undrawn revolving credit 53 Senior Convertible Notes 53 nonconvertible debt 53 bakery cafe sales 53 Second Quarter Highlights 53 = Earnings [019] 53 theprior 53 Traditional IRAs 53 NAREIT FFO 53 Liquidation Preference 53 InfoSpherix subsidiary 53 Pretax unrealized gains 53 EITF #-#-# 53 GLJ Report 53 Equinix excludes 53 FRBNY Credit Facility 53 loan chargeoffs 53 invoiced shipment 53 Marbob acquisition 53 C Convertible Preferred 53 repurchase authorization 53 OPEB obligations 53 pension curtailment 53 PLAVIX R 53 Tecstar Automotive Group 53 - CASH FLOWS [012] 53 retroactive restatement 53 SEK #,#,#,# 53 - - [054] 53 Existing Warrants 53 non cancelable lease 53 MA PFFS 53 Vyvx advertising 53 - Adjusted [016] 53 mildly dilutive 53 adopting FIN 53 EBITDA1 53 MuniPreferred 53 ANOI 53 unexpended balance 53 c Includes 53 buyback authorization 53 b Relates 53 noncash pretax 53 liquidating distributions 53 Fine Chemicals segment 53 Canaccord Relief Program 53 Vacation Interval sales 53 Susquehanna Bancshares Inc 53 address inadvertent miscalculations 53 Evercore LP 53 Accounting Guideline 53 Items impacting comparability 53 Normalized EBITDA 53 Inc. OTC CDCO 53 Liquid Yield Option 53 Preneed funeral sales 53 Debt Extinguishment 53 SFAS #R 53 LTM Adjusted EBITDA 53 unallocated ESOP shares 53 involve risks anduncertainties 53 reinsurance recoverables 53 Drivetrain segment 53 AOCI 53 Adjusted pro forma 53 unproved properties 53 Northwind Holdings 53 Fairquest 53 Cortelco Shanghai 53 ASC Topic 53 Proved undeveloped reserves 53 withholdable payment 53 undistributed profits 53 restated financials 53 React NTI 53 calculating distributable cash 53 expenses LOE 53 depreciable asset 53 Qualcomm Strategic Initiatives 53 AMEX ABL 53 NOVT 53 Cheniere Partners 53 Teekay Offshore Teekay LNG 52 TOFUTTI BRANDS INC. 52 Stub Period 52 Escrowed Proceeds 52 Non Controlling Interests 52 Fabricated Products segment 52 shares issuable pursuant 52 Adjusted Operating Expenses 52 Asset Retirement Obligations 52 DAC offsets 52 AMF Ultra Short 52 ROACE 52 - Adjusted [034] 52 Senior Secured Debt 52 USD#.#m USD#.# per [001] 52 Senior Subordinated Convertible Notes 52 Symphony ViDA 52 Adjusted Diluted EPS 52 c Excludes 52 NOL carryback 52 ReHo 52 mandatorily redeemable preferred 52 noncash pretax impairment 52 unbilled receivables 52 FASB #R 52 DonTech 52 distributable earnings 52 antibody humanization patents 52 owned OREO 52 noncurrent assets 52 Private SecuritiesLitigation Reform Act 52 Dropdown Predecessor 52 Hedge ineffectiveness 52 believes EBDDT 52 thefourth quarter 52 OPEB liability 52 OREO properties 52 noninterest expense totaled 52 including withoutlimitation 52 CDO financings 52 FFOM 52 EBITDAS 52 EPADS estimate 52 DJO Merger 52 NASDAQ HLTH 52 theglobe.com inc 52 Contingent Convertible Senior Subordinated 52 policyholder dividends 52 MtM gains 52 dacetuzumab collaboration 52 ZDP Shares 52 PFICs 52 FAS #R 52 modestly dilutive 52 Lifts Quarterly Dividend 52 deductible IRAs 52 contractually specified 52 Bois d' Arc's 52 adopting IFRS 52 LPT Agreement 52 FFO Measures 52 - Weighted average [004] 52 footnotes thereto 52 Regulated Businesses 52 pretax goodwill impairment 52 EURO#.# [002] 52 SS NOI helps 52 Mircette R 52 From Operations AFFO 52 Stock Repurchase Program 52 Valuation allowance 52 pretax noncash charges 52 excludes unrealized gains 52 COHT 52 Unlevered free 52 DNOI 52 uncollectible receivables 52 Parke Bancorp 52 IREX joint venture 52 DIP Facility 52 Proposed Offering 52 prepayable 52 AUGRID Corporation 52 Share Repurchase Plan 52 MCLP 52 Adjusted Distributable Cash 52 ratably 52 accrual status 52 CASH FLOWS PROVIDED BY 52 Adjusted EBITDA 52 ASC Subtopic #-# 52 quarter offiscal 52 Convertible Subordinated Debt 52 Visa MasterCard antitrust 52 accreted principal 52 reinsurance recoveries 52 RiverSource Life 52 #.#/BOE [002] 52 RSUs vest 52 NYSE VNR Vanguard 52 AcG 52 SIFT Rules 52 Adjusted EBITDAR 52 thethird quarter 52 Doubtful Accounts 52 Adjusted Gross Profit 52 Non Controlling Interest 52 Exchangeable Senior 52 BPE Segment 52 adopted SFAS 52 non capitalizable 52 Items excluded 52 profi ts 52 APB# 52 Consolidated adjusted EBITDA 52 convertible subordinated debentures 52 FIFO inventory 52 Nonutility 52 millionand 52 hydrovac units 52 unsecured convertible debentures 52 Omnibus Incentive Plan 52 NLASCO 52 Non GAAP Adjusted 52 Distributable Earnings 52 goodwill intangible 52 affecting comparability 52 adequately collateralized 52 Och Ziff Operating 52 Exchangeable LP units 52 Privileged Access 52 earnout provision 52 loss carryback 52 ONEOK Partners segment 52 FNLC 52 disqualifying dispositions 52 FHLB advances decreased 52 #.#bln rbl [003] 52 Reclassification adjustment 52 VaxGen stockholders 52 Repurchased shares 52 mandatorily convertible preferred 52 excluding goodwill impairment 52 MMCFEPD 52 Realised Earnings 52 Geomark 52 LYONs 52 = Basic [015] 52 BCGI Shareholders 52 consolidated balance sheets 52 antidilutive 52 PharmaBio 52 OREO valuation 52 Swap Transactions 52 Brooks Eckerd acquisition 52 severance accruals 52 OREO write downs 52 TOBs 52 unrealized hedging 52 unamortised 52 netsales 52 ThaiLin 52 LIFO inventory reserve 52 Debenture Indenture 52 CICA Handbook section 52 commodity derivative instruments 52 unreserved undesignated general 52 EnerCare 52 DEPS 52 NPREIT 52 thequarter 52 reestimates 52 Synergetics Missouri 52 Cleco Midstream 52 EGI Financial 52 interim condensed consolidated 52 self insured retentions 52 ApothecaryRx 52 Qualified Dividends 52 BlackRock LTIP shares 52 - NeDEFENDERS 52 LIQUIDITY AND 52 Mavrix Mutual Funds 52 Total Leverage Ratio 52 No. #R SFAS 52 PERH 52 amortized cost 52 SFAS# 52 JDA SOFTWARE GROUP INC. 52 Comparable bakery cafe 52 g Represents 52 Zero Coupon Convertible Notes 52 bond indentures 52 Capstead 52 Varvarinskoye Project 52 Gujiao facility 52 Visit www.transre.com 52 Derivative Liabilities 52 marketable securities totaled 52 quarterended 52 OP Units 52 unvested restricted shares 52 Total Liabilities #,#.# #,#.# [001] 52 LPBP 52 DPAC amortization 52 Section #/#K 52 Position APB #-# 52 earnouts 52 Currency translation 52 reasonably determinable 52 identifiable intangibles 52 noncancelable 52 hedging derivative instruments 51 indebtedness incurred 51 3Q FY# 51 unaudited consolidated balance sheet 51 Contingent Value Right 51 Unfunded pension 51 promissory note payable 51 Maritech 51 NOARK Pipeline System 51 - - NetMarigot Bay r 51 historicalfacts 51 Goodwill Impairment Charge 51 FASB Statement 51 Vnus 51 unexercised options 51 excluding depreciation depletion 51 FIFO EBITDA 51 -By Cliodhna McGowan 51 Designer Intimates 51 - Adjusted [028] 51 Offerors Commercial applies 51 WWS Divestiture 51 = Earnings [026] 51 noncash accounting 51 AMPAC ISP Holdings 51 adopting FAS #R 51 MSR valuation 51 B Cumulative Preferred 51 PMPS brand 51 Pro Forma Adjusted EBITDA 51 Polymer Additives segment 51 subordinated debentures 51 unrealized depreciation 51 Distributable Income 51 regarding Heska 51 Convertible Notes validly tendered 51 Coulbourn Instruments 51 TruOFFICE subscribers 51 unamortized premiums 51 Fully Taxed EPS 51 warrants expired unexercised 51 Enpath ability 51 Modified EBITDA 51 identifiable intangible assets 51 unrealized appreciation 51 indemnification agreements 51 capital expenditures 51 intercompany loans 51 UNII Balance Average 51 NextRx pharmacy benefit 51 income allocable 51 vested RSUs 51 EFFECT OF FOREIGN CURRENCY 51 Existing Debentures 51 consolidated OIBDA 51 CTT Holdings 51 Payment SFAS #R 51 EIFH 51 thispress release 51 PIXMA MX# Office 51 Incentive Compensation Plan 51 Anhui Jucheng 51 DXL TM antibodies 51 unaccreted 51 aresubject 51 adjusted OIBDA margin 51 unsecured promissory notes 51 NEGT 51 overcollateralization tests 51 SFAS No. 51 Mezzanine Loan 51 Embedded Derivatives 51 - - Nforecaddie 51 Noninterest expense totaled 51 Early Settlement Date 51 Interest accrues 51 Toggle Notes 51 Separate Subordinated Notes 51 SSNOI 51 KFSI 51 Free Cash Flow 51 Previously Securitized Loans 51 DIP Loan 51 Biolevier loan facility 51 LICT 51 DIP financing facility 51 Impaired loans 51 Vinyls segment 51 PBIH 51 proforma EPS 51 Distribution FAD 51 PWOD 51 IRC § 51 ElderTrust 51 contingent earnout 51 leaseback transactions 51 Van Kampen Closed End 51 Preclinical eValuation 51 fourth OSV newbuild 51 NOI decreased 51 Trustreet 51 SunPower incurs amortization 51 Mandatory Convertible Notes 51 Products Declare Monthly 51 Variable Interest Entities VIEs 51 Scheme Consideration 51 DMRJ 51 EPE unitholders 51 Proposed Financing 51 = Weighted average [026] 51 Conversion Price 51 OPEB obligation 51 unabsorbed overhead 51 CMHC insured mortgages 51 RedWater 51 Newell Rubbermaid Declares Dividend 51 PHYH 51 DXD Fund 51 Shelf Registration Statement 51 EBITD 51 excluding QSI 51 Interest Coverage Ratio 51 QTDP Program 51 MetaPower International 51 Tax Expense 51 Adjusted EBITDAS 51 Illumigen Biosciences Inc. 51 LIFO inventory adjustments 51 MSR hedging 51 NON CASH EXPENSES 51 PrivateSecurities Litigation Reform Act 51 unrealized gains 51 USD#.#m [008] 51 consents authorizations 51 FCGH 51 - - Net [052] 51 Proforma EBITDA 51 EMEA Subsidiaries 51 DSL.net s 51 depletable base 51 Subordinated Notes Due 51 SFY #-# 51 TSX GVC 51 Extra Ordinary Items 51 expense LOE 51 Tangible Equity Units 51 Compensation Expenses 51 EBITDA adjusted EBITDA 51 Secured Facility 51 leasehold acquisitions 51 Instalment Reinvestment Plan 51 contingently issuable